Stock Events

Stock Events

Search...

Quantum Genomics

€0.07

11

-€0-1.77% Thursday 15:35

Statistics

Day High

0.07

Day Low

0.07

52W High

0.07

52W Low

0.07

Volume

128,880

Avg. Volume

0

Mkt Cap

5.03M

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

26FebExpected

Q1 2023

Q3 2023

Q4 2023

Q1 2024

Q2 2024

Q3 2024

Q4 2024

0

0.33

0.67

1

Expected EPS

N/A

Actual EPS

N/A

Financials

-Profit Margin

Unprofitable

2019

2020

2021

2022

2023

2024

0Revenue

-17.78MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ALQGC.PA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Quantum Genomics in the development of cardiovascular drugs.

Pfizer is a large pharmaceutical company with a broad product portfolio, including treatments for cardiovascular diseases, making it a competitor to Quantum Genomics.

Merck & Co., Inc. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals, including those for cardiovascular health, competing with Quantum Genomics.

AstraZeneca operates in the biopharmaceutical sector, focusing on the development of drugs for various diseases, including cardiovascular, which competes with Quantum Genomics' focus.

Amgen is a biopharmaceutical company that develops and manufactures innovative human therapeutics, including cardiovascular drugs, competing with Quantum Genomics.

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines, including for cardiovascular diseases, making it a competitor to Quantum Genomics.

Johnson & Johnson

Johnson & Johnson operates in the pharmaceutical sector with a wide range of products, including cardiovascular drugs, directly competing with Quantum Genomics.

GlaxoSmithKline is a healthcare company that researches and develops a wide range of medicines, including those for cardiovascular diseases, competing with Quantum Genomics.

Sanofi is a global healthcare leader that discovers, develops, and distributes therapeutic solutions, including for cardiovascular diseases, making it a competitor to Quantum Genomics.

AbbVie is a biopharmaceutical company that has a range of products for various therapeutic areas, including cardiovascular diseases, competing with Quantum Genomics.

About

Quantum Genomics Société Anonyme, a healthtech company, develops of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.

Show more...

CEO

Mr. Mathieu Bigois

Employees

1

Country

FR

ISIN

FR0011648971

Listings

0 Comments

Share your thoughts

FAQ

What is Quantum Genomics stock price today?▼

The current price of ALQGC.PA is €0.07 EUR — it has decreased by -1.77% in the past 24 hours. Watch Quantum Genomics stock price performance more closely on the chart.

What is Quantum Genomics stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Quantum Genomics stocks are traded under the ticker ALQGC.PA.

What is Quantum Genomics market cap?▼

Today Quantum Genomics has the market capitalization of 5.03M

What is Quantum Genomics revenue for the last year?▼

Quantum Genomics revenue for the last year amounts to 0 EUR.

What is Quantum Genomics net income for the last year?▼

ALQGC.PA net income for the last year is -17.78M EUR.

How many employees does Quantum Genomics have?▼

As of April 04, 2026, the company has 1 employees.

In which sector is Quantum Genomics located?▼

Quantum Genomics operates in the Health Care sector.

When did Quantum Genomics complete a stock split?▼

Quantum Genomics has not had any recent stock splits.

Where is Quantum Genomics headquartered?▼

Quantum Genomics is headquartered in Paris, FR.